Neutrophil-lymphocyte ratio as a prognostic tool for the evaluation of laryngeal carcinoma

Ashish Sharma, S. K. Kanaujia, Sandeep Kaushik, Amrita Srivastava


Background: The objective of the study was to review the neutrophil lymphocyte ratio (NLR) as a prognostic tool in carcinoma larynx.

Methods: Patients who were fulfilling inclusion criteria after screening were selected for study. On the basis of cutoff pretreatment NLR (<3 or >3) divided into two groups high pretreatment NLR and low pretreatment NLR. Patient undergo chemo or radiotherapy and at the end of follow up these two group NLR were compared with tumor negative prognostic score, survival at the end of follow up, resolving of symptoms, staging change, tumor regression and overall prognosis at the end of follow up were assessed.

Results: Mean value of tumor negative prognostic score of early carcinoma with low NLR, early carcinoma with high NLR, late carcinoma with low NLR and late carcinoma with High NLR were 13.833±2.80, 24.04±4.5538, 37.833±8.68 and 55.33±6.429 respectively. 10 (17.5%) patients with high NLR show more than 50% tumor regression while 17 (29.82%) with high NLR show <50% tumor regression. 26 (45.61%) patients with low NLR show >50% tumor regression and 4 (7.01%) show <50% tumor regression.

Conclusions: It was concluded in our study that pretreatment NLR is an acceptable prognostic tool in carcinoma larynx. High NLR was associated with poor prognosis and low NLR was associated with better prognosis.


Neutrophil/lymphocyte ratio, Laryngeal carcinoma, Tumor negative prognostic score

Full Text:



Eskiizmir G, Uz U, Onur E. The evaluation of pretreatment neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio in patients with laryngeal neoplasms. Braz J Otorhinolaryngol. 2018.

Engin BHS¸ Ulas EAG¸ Alabalık Fazıl Emre O¨ zkurt Mehmet Akdag˘ I ˙smail Topc. Neutrophil–Lymphocyte Ratio as a Prognostic Factor in Laryngeal Carcinoma. Indian J Otolaryngol Head Neck Surg. 2018;70(2):175-9.

Duzlu M, Karamert R, Tutar H, Karaloglu F, Sahin M, Cevizci R. Neutrophil-lymphocyte ratio findings and larynx carcinoma: a preliminary study in Turkey. Asian Pac J Cancer Prev. 2015;16(1):351.

Tu XP, Qiu QH, Chen LS, Luo XN, Lu ZM, Zhang SY, et al. Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell car-cinoma. BMC Cancer. 2015;15:743.

Zeng YC, Chi F, Xing R, Xue M, Wu LN, Tang MY et al. Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Japanese Journal of Clinical Oncology. 2016;46(2):126-31.

Fu Y, Liu W, Ouyang D, Yang A, Zhang Q. Preoperative neutrophil-to-lymphocyte ratio predicts long-term survival in patients undergoing total laryngectomy with advanced laryngeal squamous cell carcinoma: a single-center retrospective study. Medicine (Baltimore). 2016;95(6):e2689.

Kum RO, Ozcan M, Baklaci D, Kum NY, Yilmaz YF, Gungor V, et al. Elevated Neutrophil-to-Lymphocyte Ratio in Squamous Cell Carcinoma of Larynx Compared to Benign and Precancerous Laryngeal Lesions. Asian Pacific J Cancer Prevent. 2014;15(17):7351-5.

Hsueh C, Tao L, Zhang M, Cao W, Gong H, Zhou J et al. The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer. Oncotarget. 2017;8(36):60514-27.